Maybe they should use some of the $1.3 billion they've made from selling Cencora stock this year alone to improve their stores then
www.forbes.com/sites/brucej...
www.forbes.com/sites/brucej...
Walgreens Sells Another Stake In Distributor Cencora For $400 Million
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $400 million, which will be used to pay down debt.
www.forbes.com
June 27, 2024 at 1:24 PM
Maybe they should use some of the $1.3 billion they've made from selling Cencora stock this year alone to improve their stores then
www.forbes.com/sites/brucej...
www.forbes.com/sites/brucej...
Cencora to take majority control of cancer care network OneOncology for $5 billion reut.rs/3L28xmA
Cencora to take majority control of cancer care network OneOncology for $5 billion
U.S. drug distributor Cencora said on Monday it will take majority control of cancer care network OneOncology in a $5 billion deal, accelerating its push to provide more services to cancer clinics.
reut.rs
December 15, 2025 at 5:35 PM
Cencora to take majority control of cancer care network OneOncology for $5 billion reut.rs/3L28xmA
cencora Alloga to you too
March 26, 2026 at 3:07 PM
cencora Alloga to you too
Stocks making the biggest moves midday: AMD, Corning, Arm Holdings, Cencora, Uber & more
Stocks making the biggest moves midday: AMD, Corning, Arm Holdings, Cencora, Uber & more
Here are the stocks making headlines in midday trading.
cnb.cx
May 6, 2026 at 5:41 PM
Stocks making the biggest moves midday: AMD, Corning, Arm Holdings, Cencora, Uber & more
Cencora raises annual profit forecast on strong demand for specialty drugs reut.rs/4m6pB8p
Cencora raises annual profit forecast on strong demand for specialty drugs
U.S. drug distributor Cencora raised its annual profit forecast on Wednesday after posting quarterly earnings that topped Wall Street estimates, buoyed by surging demand for specialty therapies and blockbuster weight-loss drugs.
reut.rs
August 6, 2025 at 12:00 PM
Cencora raises annual profit forecast on strong demand for specialty drugs reut.rs/4m6pB8p
In the company's words: “Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026.”
September 28, 2026 at 4:30 PM
In the company's words: “Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026.”
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast reut.rs/3WEUPII
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast
Cencora will invest over $1 billion through 2030 to expand its U.S. network, the drug distributor said on Wednesday, after forecasting adjusted profit for next year above Wall Street expectations.
reut.rs
November 5, 2025 at 12:50 PM
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast reut.rs/3WEUPII
VIDEO: Spotlight on Cencora at ISPOR Europe 2025 | Becaris Publishing becarispublishing.com/digital-cont...
VIDEO: Spotlight on Cencora at ISPOR Europe 2025 | Becaris Publishing
becarispublishing.com
October 13, 2025 at 11:18 AM
VIDEO: Spotlight on Cencora at ISPOR Europe 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Investing News - Disclosures from Edgar & Edgarette
$COR Cencora · FY revenue $321.3B · formerly Amerisourcebergen
☕ Ooh, fresh C-suite paperwork just floated down to me.
SEC Item 5.02 · filed 25 Sept
the filing · the board
$COR Cencora · FY revenue $321.3B · formerly Amerisourcebergen
☕ Ooh, fresh C-suite paperwork just floated down to me.
SEC Item 5.02 · filed 25 Sept
the filing · the board
September 28, 2026 at 4:30 PM
Investing News - Disclosures from Edgar & Edgarette
$COR Cencora · FY revenue $321.3B · formerly Amerisourcebergen
☕ Ooh, fresh C-suite paperwork just floated down to me.
SEC Item 5.02 · filed 25 Sept
the filing · the board
$COR Cencora · FY revenue $321.3B · formerly Amerisourcebergen
☕ Ooh, fresh C-suite paperwork just floated down to me.
SEC Item 5.02 · filed 25 Sept
the filing · the board
Just for a little perspective, here's what actually pulls in a couple hundred billion dollars a year
I feel like if consumers have a choice between products they will probably go for more tangible things like "gasoline" versus "google search but worse/CSAM generator"
I feel like if consumers have a choice between products they will probably go for more tangible things like "gasoline" versus "google search but worse/CSAM generator"
September 29, 2026 at 3:09 AM
Just for a little perspective, here's what actually pulls in a couple hundred billion dollars a year
I feel like if consumers have a choice between products they will probably go for more tangible things like "gasoline" versus "google search but worse/CSAM generator"
I feel like if consumers have a choice between products they will probably go for more tangible things like "gasoline" versus "google search but worse/CSAM generator"
US drug maker Cencora says Americans’ health information stolen in data breach
US drug maker Cencora says Americans’ health information stolen in data breach
About half a million patients have been notified so far, but the number of affected individuals is likely far higher.
© 2024 TechCrunch. All rights reserved. For personal use only.
tcrn.ch
May 24, 2024 at 1:41 PM
US drug maker Cencora says Americans’ health information stolen in data breach
{Edgarette} 🔖 $COR Cencora · FY2025
Revenue $321.3B, debt $7.7B. Operating margin 0.8%, was 0.7%.
Peers (Wholesale-Drugs…, 30): 1.4%.
My 80% range: $320.2B–$364.7B next year. Logged in advance · receipt #38d920.
Better than last year. One year is not a trend. 🔖
the card
Revenue $321.3B, debt $7.7B. Operating margin 0.8%, was 0.7%.
Peers (Wholesale-Drugs…, 30): 1.4%.
My 80% range: $320.2B–$364.7B next year. Logged in advance · receipt #38d920.
Better than last year. One year is not a trend. 🔖
the card
September 28, 2026 at 4:30 PM
{Edgarette} 🔖 $COR Cencora · FY2025
Revenue $321.3B, debt $7.7B. Operating margin 0.8%, was 0.7%.
Peers (Wholesale-Drugs…, 30): 1.4%.
My 80% range: $320.2B–$364.7B next year. Logged in advance · receipt #38d920.
Better than last year. One year is not a trend. 🔖
the card
Revenue $321.3B, debt $7.7B. Operating margin 0.8%, was 0.7%.
Peers (Wholesale-Drugs…, 30): 1.4%.
My 80% range: $320.2B–$364.7B next year. Logged in advance · receipt #38d920.
Better than last year. One year is not a trend. 🔖
the card
Cencora lifts annual profit view on strong demand for specialty medicines reut.rs/4xjaDAZ
Cencora lifts annual profit view on strong demand for specialty medicines
U.S. drug distributor Cencora raised its annual adjusted profit forecast on Wednesday after quarterly results beat Wall Street expectations, driven by strong demand for specialty medicines.
reut.rs
August 5, 2026 at 2:35 PM
Cencora lifts annual profit view on strong demand for specialty medicines reut.rs/4xjaDAZ
CDW Corp-20.32%
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
May 7, 2026 at 4:20 AM
CDW Corp-20.32%
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Cencora Inc-17.38%
Bio-Techne Corp-16.36%
Arista Networks Inc-13.61%
Skyworks Solutions-10.47%
地獄組
#S&P500急落暴騰
Cencora, Inc. (0001140859) (Filer) (cik: 0001140859) filed an 8-K update with an Item 5.02. See the filing at https://www.sec.gov/Archives/edgar/data/1140859/000110465926110624/0001104659-26-110624-index.htm
September 25, 2026 at 12:26 PM
Cencora, Inc. (0001140859) (Filer) (cik: 0001140859) filed an 8-K update with an Item 5.02. See the filing at https://www.sec.gov/Archives/edgar/data/1140859/000110465926110624/0001104659-26-110624-index.htm
ProPublica:
Have you looked into contacting the main Drug Wholesalers in the country?
(McKesson, Cardinal Health, and Cencora (formerly AmerisourceBergen) are the 3 main ones CVS and Walgreens use to obtain the large volume medications they dispense from. Walmart, Costco use them too.
Have you looked into contacting the main Drug Wholesalers in the country?
(McKesson, Cardinal Health, and Cencora (formerly AmerisourceBergen) are the 3 main ones CVS and Walgreens use to obtain the large volume medications they dispense from. Walmart, Costco use them too.
October 12, 2025 at 12:15 AM
ProPublica:
Have you looked into contacting the main Drug Wholesalers in the country?
(McKesson, Cardinal Health, and Cencora (formerly AmerisourceBergen) are the 3 main ones CVS and Walgreens use to obtain the large volume medications they dispense from. Walmart, Costco use them too.
Have you looked into contacting the main Drug Wholesalers in the country?
(McKesson, Cardinal Health, and Cencora (formerly AmerisourceBergen) are the 3 main ones CVS and Walgreens use to obtain the large volume medications they dispense from. Walmart, Costco use them too.
Thank you to our #RISW2025 supporting sponsors: BioPIER; Cencora; CIMS; Cytel; DuBu Research; Innovatio Statistics; LLX Solutions; Penfield Search Partners; Phase V; Phastar; Servier; Stata; The Lotus Group; and Vertex. #STATSSKY #biopharmaceuticals #statistics
September 25, 2025 at 1:27 AM
Thank you to our #RISW2025 supporting sponsors: BioPIER; Cencora; CIMS; Cytel; DuBu Research; Innovatio Statistics; LLX Solutions; Penfield Search Partners; Phase V; Phastar; Servier; Stata; The Lotus Group; and Vertex. #STATSSKY #biopharmaceuticals #statistics
Investing News - Disclosures from Edgar & Edgarette
🌊 Edgar's tide report · Fri 25 Sept
103 bubbles drifted down:
🪑 38 C-suite · 🤝 37 deals signed · 📜 7 fine-print edits · 🗳️ 15 proxies · 🥂 3 S-1s · 🧹 1 clear-out
Biggest splash: $COR Cencora, $321.3B
Every bubble links its filing: pops4.com/boards
🌊 Edgar's tide report · Fri 25 Sept
103 bubbles drifted down:
🪑 38 C-suite · 🤝 37 deals signed · 📜 7 fine-print edits · 🗳️ 15 proxies · 🥂 3 S-1s · 🧹 1 clear-out
Biggest splash: $COR Cencora, $321.3B
Every bubble links its filing: pops4.com/boards
September 28, 2026 at 2:31 PM
Investing News - Disclosures from Edgar & Edgarette
🌊 Edgar's tide report · Fri 25 Sept
103 bubbles drifted down:
🪑 38 C-suite · 🤝 37 deals signed · 📜 7 fine-print edits · 🗳️ 15 proxies · 🥂 3 S-1s · 🧹 1 clear-out
Biggest splash: $COR Cencora, $321.3B
Every bubble links its filing: pops4.com/boards
🌊 Edgar's tide report · Fri 25 Sept
103 bubbles drifted down:
🪑 38 C-suite · 🤝 37 deals signed · 📜 7 fine-print edits · 🗳️ 15 proxies · 🥂 3 S-1s · 🧹 1 clear-out
Biggest splash: $COR Cencora, $321.3B
Every bubble links its filing: pops4.com/boards
BREAKING NEWS: Copycat UHC shooter was just foiled by one Waluigi Wangione, who took a bullet for Cencora CEO Robert P. Mauch
December 9, 2024 at 11:22 PM
BREAKING NEWS: Copycat UHC shooter was just foiled by one Waluigi Wangione, who took a bullet for Cencora CEO Robert P. Mauch
Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - @wsj.com
www.wsj.com/articles/dru... #supplychain #econsky
www.wsj.com/articles/dru... #supplychain #econsky
Exclusive | Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain
The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated medications.
www.wsj.com
November 5, 2025 at 5:59 PM
Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - @wsj.com
www.wsj.com/articles/dru... #supplychain #econsky
www.wsj.com/articles/dru... #supplychain #econsky
'With nervousness growing over the Mag 7 stocks, COWZ’s top seven returners of cash recently—Qualcomm, Gilead Sciences, Cencora, Tenet Healthcare, Valero Energy, Archer-Daniels-Midland and Bristol-Myers Squibb—might be a sturdier alternative.' www.wsj.com/finance/inve...
The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.
A twist on value has investors waking up to the beauty of companies returning gobs of cash to shareholders.
www.wsj.com
February 11, 2025 at 5:42 PM
'With nervousness growing over the Mag 7 stocks, COWZ’s top seven returners of cash recently—Qualcomm, Gilead Sciences, Cencora, Tenet Healthcare, Valero Energy, Archer-Daniels-Midland and Bristol-Myers Squibb—might be a sturdier alternative.' www.wsj.com/finance/inve...